200020012002200320042005200620072008
Pages:
«<129130131132133
NOTICES: Proposed collection; comment request,
Published: 2001-01-05
The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on the proposed collection of certain
information by the agency. Under the Paperwork Reduction Act of 1995
(the PRA), Federal agencies are required to publish a notice in the
Federal Register concerning each proposed collection of information,
including each
NOTICES: Proposed collection; comment request,
Published: 2001-01-05
The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on the proposed collection of certain
information by the agency. Under the Paperwork Reduction Act of 1995
(the PRA), Federal agencies are required to publish notice in the
Federal Register concerning each proposed collection of information,
including each
NOTICES: Submission for OMB review; comment request,
Published: 2001-01-05
The Food and Drug Administration (FDA) is announcing that the
proposed collection of information listed below has been submitted to
the Office of Management and Budget (OMB) for review and clearance
under the Paperwork Reduction Act of 1995.
RULES: Gentamicin sulfate, mometasone furoate, clotrimazole otic suspension,
Published: 2001-01-04
The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect approval of a new animal drug application
(NADA) filed by ScheringPlough Animal Health Corp. The NADA provides
for veterinary prescription use of gentamicin/mometasone/clotrimazole
otic suspension to treat otitis externa in dogs.
RULES: Sponsor name and address changes—; Phoenix Scientific, Inc.,
Published: 2001-01-04
The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect a change of sponsor for two approved new
animal drug applications (NADA's) from Pfizer, Inc., to Phoenix
Scientific, Inc.
NOTICES: Industry initiatives pilot program expansion,
Published: 2001-01-04
The Food and Drug Administration (FDA) is announcing some
changes in its standard practices for medical device, drug, food, and
biologics inspections based on the outcome of the expansion of the
medical device industry initiatives pilot program. FDA is discontinuing
the practice of postinspection notification letters for all
inspections because
NOTICES: Potassium iodine as thyroid blocking agent in radiation emergencies,
Published: 2001-01-04
The Food and Drug Administration (FDA) is announcing the
availability of a draft guidance entitled ``Potassium Iodide as a
Thyroid Blocking Agent in Radiation Emergencies.'' This draft guidance
updates a notice of availability entitled ``Potassium Iodide as a
ThyroidBlocking Agent In a Radiation Emergency: Final Recommendations
On Use'' published
NOTICES: Troy Corp.,
Published: 2001-01-03
The Food and Drug Administration (FDA) is amending the filing
notice for a food additive petition filed by Troy Corp. to indicate
that the petitioner has proposed that the food additive regulations be
amended to provide for the safe use of butanedioic acid, sulfo1,4
diisodecyl ester, ammonium salt as a surface active agent in
NOTICES: Proposed collection; comment request,
Published: 2001-01-03
The Department of Health and Human Services, Office of the
Secretary will periodically publish summaries of proposed information
collections projects and solicit public comments in compliance with the
requirements of Section 3506(c)(2)(A) of the Paperwork Reduction Act of
1995. To request more information on the project or to obtain a copy of
RULES: Clopyralid,
Published: 2001-01-03
The inventions listed below are owned by agencies of the U.S.
Government and are available for licensing in the U.S. in accordance
with 35 U.S.C. 207 to achieve expeditious commercialization of results
of federallyfunded research and development. Foreign patent
applications are filed on selected inventions to extend market coverage
NOTICES: State Children's Health Insurance Program,
Published: 2001-01-03
This notice sets forth the final allotments of Federal funding
available to each State, the District of Columbia, and each U.S.
Territory and Commonwealth for fiscal year (FY) 2001 under title XXI of the Social Security Act (the Act).
Established by section 4901 of the Balanced Budget Act of 1997, and
amended by the Medicare, Medicaid and SCHIP
NOTICES: Head Start Research and Evaluation Advisory Committee,
Published: 2001-01-03
The 1998 Head Start Reauthorization (42 U.S.C. 9844(g);
section 649(g)(1) of the Head Start Act, as amended) called on the
Secretary of Health and Human Services to form an independent panel of
experts (i.e., an Advisory Committee) to offer advice concerning
research designs that would provide a national analysis of the impact
of Head Start
NOTICES: Proposed collection; comment request,
Published: 2001-01-03
The inventions listed below are owned by agencies of the U.S.
Government and are available for licensing in the U.S. in accordance
with 35 U.S.C. 207 to achieve expeditious commercialization of results
of federallyfunded research and development. Foreign patent
applications are filed on selected inventions to extend market coverage
NOTICES: Proposed collection; comment request,
Published: 2001-01-03
The inventions listed below are owned by agencies of the U.S.
Government and are available for licensing in the U.S. in accordance
with 35 U.S.C. 207 to achieve expeditious commercialization of results
of federallyfunded research and development. Foreign patent
applications are filed on selected inventions to extend market coverage
NOTICES: Proposed collection; comment request,
Published: 2001-01-03
The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on the proposed collection of certain
information by the agency. Under the Paperwork Reduction Act of 1995
(the PRA), Federal agencies are required to publish notice in the
Federal Register concerning each proposed collection of information,
including each
NOTICES: R.J. Corman Railroad Co. et al.,
Published: 2001-01-03
The inventions listed below are owned by agencies of the U.S.
Government and are available for licensing in the U.S. in accordance
with 35 U.S.C. 207 to achieve expeditious commercialization of results
of federallyfunded research and development. Foreign patent
applications are filed on selected inventions to extend market coverage
NOTICES: Reporting and recordkeeping requirements,
Published: 2001-01-03
The Food and Drug Administration (FDA) is announcing that a
collection of information entitled ``Guidance for Industry on How to
Use EMail to Submit a Notice of Intent to Slaughter for Human Food
Purposes'' has been approved by the Office of Management and Budget
(OMB) under the Paperwork Reduction Act of 1995.
NOTICES: Submission for OMB review; comment request,
Published: 2001-01-03
The Food and Drug Administration (FDA) is announcing that the
proposed collection of information listed below has been submitted to
the Office of Management and Budget (OMB) for review and clearance
under the Paperwork Reduction Act of 1995.
NOTICES: Health Services Research Initial Review Group,
Published: 2001-01-02
In accordance with section 10(d) of the Federal Advisory Committee
Act as amended (5 U.S.C., Appendix 2), The Agency for Healthcare
Research and Quality (AHRQ) announces meetings of scientific peer
review groups. The subcommittees listed below are part of the Agency's Health Services research Initial Review Group Committee.
The subcommittee